Disruptive technology award faculty
2026 DTAC committee
Khushbu Patel, PhD, DABCC, FADLM (Chair)
Director, Clinical Chemistry and Point-of-Care, Children’s Hospital of Philadelphia
Assistant Professor of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania
Philadelphia, Pennsylvania
Susan Evans, PhD, FADLM
Principal
BioDecisions Consulting
Los Gatos, California
Michaela Miller, MBA
Senior Director, Strategy & Marketing
Thermo Fisher Scientific
Boston, Massachusetts
Vincent Ricchiuti, PhD, HCLD(ABB), FADLM
Laboratory Director and Discipline Director in Immunology
LabCorp
Dublin, Ohio
Alicja Santos, PhD
CEO
Polonium Foundation
Los Angeles, California
Arejas (Jim) Uzgiris, PhD
Senior Director, R&D
Siemens Healthcare DIagnostics
Berkeley, California
2026 Finalist Judges
Trevor Hawkins, PhD
Chairman, Genomtec S.A
Board Member & Audit Chair, Blue Water Acquisition Corp IV
Greenwich, CT
Donna Hochberg, PhD
Partner and Managing Director
Head of Dx, PM, and LST & Services
Health Advances
Boston, MA
Robert H. Raynor, PhD, MBA
Consultant: Clinical Diagnostics, Technical and Market Diligence, Mergers and Acquisitions
Pismo Beach, CA
2026 Reviewers
Chris Farnsworth, PhD
Washington University in St. Louis
St. Louis, Missouri
Laura Filkins, PhD, D(ABMM)
University of Texas Southwestern Medical Center
Dallas, Texas
Dianne Keen-Kim, PhD
Natera
San Carlos, CA
David Ledden, PhD
Siemens Healthineers
Elkhart, Indiana
Giles Sanders, PhD
TTP plc
Cambridgeshire, United Kingdom
Manfred Scholz, PhD
Scholz Consulting Partners LLC
Medford, Massachusetts

